Approvals/CIMA-AEMPS/BALZAK PLUS 40 mg/5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

BALZAK PLUS 40 mg/5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Menarini International Operations Luxembourg S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: cc8e33ba226ffdc1
Drug Cima Aemps Name: BALZAK PLUS 40 mg/5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: BE390503
Holder Company Name: Menarini International Operations Luxembourg S.A.
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/menarini-international-operations-luxembourg-s-a
Authorization Date: 2020-11-04
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 40 mg/5mg/25 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Menarini International Operations Luxembourg S.A.
Company Detail Path: /organization/menarini-international-operations-luxembourg-s-a

OLMESARTAN MEDOXOMILO

40 mg

AMLODIPINO BESILATO

6,944 mg

HIDROCLOROTIAZIDA

25 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 4, 2020

Approval ID

cc8e33ba226ffdc1

Type

Standard